Tranexamic Acid
- Product NDC
- 69918-301
- 11-digit product format
- 699180301
- Labeler code
- 69918
- Product ID
- 69918-301_7bafece1-f0b8-4852-92ca-fe2bf261be04
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tranexamic Acid
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Nordic Pharma, Inc.
- Application
- NDA022430
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2016-03-01
- Substance
- TRANEXAMIC ACID
- Active strength
- 650 mg/1
- Pharmacologic classes
- Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tranexamic Acid
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TRANEXAMIC ACID | 650 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6T84R30KC1 |
| Rxcui | 883826 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69918-301-30 | Tranexamic Acid | 30 in 1 BOTTLE | TABLET | 30 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69918-301 | TRANEXAMIC ACID TABLET [AMRING PHARMACEUTICALS, INC.] | 6 | Current NDC, Legacy NDC, 1 package rows | 20221223_031bf7c2-3b07-469d-bc5a-31fc6238e25f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69918-301-30 | 69918030130 | 30 TABLET in 1 BOTTLE (69918-301-30) | 30 tablet | 2016-03-01 | 0000-00-00 | No | No | Current |